Events
October 2024
Wed .
9
Joint symposium with Oblon in Tokyo (9 Oct. 2024) and Osaka (10 Oct. 2024)
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Tue .
8
Maiwald was partner of the 3rd Annual Life Science Strategy Summit on IP & Exclusivity from October 8-10 in Munich
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Wed .
2
|Past Event|
Seminar
INTA Seminar for Paralegals in Munich, October 2, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
September 2024
Wed .
25
|Past Event|Seminar
Maiwald at FICPI in Madrid, September 25-28, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Tue .
24
|Past Event|
Fair
Maiwald will be represented at WindEnergy Hamburg 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Tue .
24
Maiwald at the Prague.bio, September 24, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Mon .
23
|Past Event|
Live lecture
MUNICH IP FORUM, September 23 & 24, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Wed .
18
Maiwald at the GRUR annual conference, September 18-20, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
August 2024
Thu .
22
Maiwald at The China Intellectual Property & Innovation Summit (CIPIS) in Shenzhen, August 22 & 23, 2024
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
June 2024
Thu .
27
Maiwald seminar in Munich (20.06.)
and Düsseldorf (27.06.)
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
Thu .
13
IP Protection for Plant Innovation 2024 – 11th International Conference
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
May 2024
Thu .
23
Online lecture: Requirements and current legal developments in the field of SPC production and stockpiling exemptions
During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...
Continue reading
